John P Maxwell

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Blood Brain Barrier

Induced Apoptosis

Anti Inflammatory

Top Venues

Journal of medicinal chemistry

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, Haris Jahic, Janid A Ali, Charles B Davis, Shanzhong Gong, Deepali Gotur, Lina Gu, Patrick McCarren, Matthew R Tonini, Alice Tsai, Erik W Wilker, Hongling Yuan, Minjie Zhang, Wenhai Zhang, Alan Huang, John P Maxwell
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP -Deleted Cancers. Journal of medicinal chemistry 67 (8) (2024)
Kevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, Haris Jahic, Janid A Ali, Charles B Davis, Shanzhong Gong, Deepali Gotur, Lina Gu, Patrick McCarren, Matthew R Tonini, Alice Tsai, Erik W Wilker, Hongling Yuan, Minjie Zhang, Wenhai Zhang, Alan Huang, John P Maxwell
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP -Deleted Cancers. Journal of medicinal chemistry 67 (8) (2024)
Kevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, Haris Jahic, Janid A Ali, Charles B Davis, Shanzhong Gong, Deepali Gotur, Lina Gu, Patrick McCarren, Matthew R Tonini, Alice Tsai, Erik W Wilker, Hongling Yuan, Minjie Zhang, Wenhai Zhang, Alan Huang, John P Maxwell
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP -Deleted Cancers. Journal of medicinal chemistry 67 (8) (2024)
Kevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, Haris Jahic, Janid A Ali, Charles B Davis, Shanzhong Gong, Deepali Gotur, Lina Gu, Patrick McCarren, Matthew R Tonini, Alice Tsai, Erik W Wilker, Hongling Yuan, Minjie Zhang, Wenhai Zhang, Alan Huang, John P Maxwell
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP -Deleted Cancers. Journal of medicinal chemistry (2024)
Antoine Simoneau, Justin L Engel, Madhavi Bandi, Katherine Lazarides, Shangtao Liu, Samuel R Meier, Ashley H Choi, Hongxiang Zhang, Binzhang Shen, Lauren Martires, Deepali Gotur, Truc V Pham, Fang Li, Lina Gu, Shanzhong Gong, Minjie Zhang, Erik Wilker, Xuewen Pan, Douglas A Whittington, Scott Throner, John P Maxwell, Yingnan Chen, Yi Yu, Alan Huang, Jannik N Andersen, Tianshu Feng
Ubiquitinated PCNA drives USP1 synthetic lethality in cancer. Molecular cancer therapeutics (2022)